The Food and Drug Administration approved Flexion Therapeutics Inc.'s (Nasdaq: FLXN) non-opioid steroid injection to treat knee pain. Shares of the pharmaceutical soared $2.81 to close at $29.93.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|